P1.17-40 Clinical Implications of Using Circulating Tumor...

Journal of Thoracic Oncology 2019 / 10 Vol. 14; Iss. 10

P1.17-40 Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment

Simon, N., Chae, Y.K., Mohindra, N., Villaflor, V.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.1313
Date:
October, 2019
File:
PDF, 376 KB
2019
Conversion to is in progress
Conversion to is failed